Catherine C. Turkel - Sep 2, 2022 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Director
Signature
/Catherine C. Turkel/
Stock symbol
LEXX
Transactions as of
Sep 2, 2022
Transactions value $
$0
Form type
4
Date filed
9/6/2022, 12:53 PM
Next filing
Oct 13, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEXX Stock Options Award $0 +3.4K $0.00 3.4K Sep 2, 2022 Common Shares 3.4K $3.04 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.